Europe Next Generation Sequencing Market Developments and Forecast by 2025

Europe Next Generation Sequencing Market to 2025 - Regional Analysis and Forecasts by Product (Platforms, Services, Consumables); Service (Genome Sequencing, Exome Sequencing, Resequencing Targeted Sequencing, & Other Sequencing Technologies); Application (Diagnostics, Drug Discovery, Precision Medicine, & Other Applications); & End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals Clinics, & Other End Users), and Country

Historic Data: 2015-2016 | Base Year: 2017 | Forecast Period: 2018-2025
  • Status : Published
  • Report Code : TIPRE00005459
  • Category : Life Sciences
  • No. of Pages : 123
  • Available Report Formats : pdf-format excel-format
  • Last update date : June 15, 2019
Europe Next Generation Sequencing Market Developments and Forecast by 2025
Report Date: June 15, 2019   |   Report Code: TIPRE00005459 Email: sales@theinsightpartners.com

2017 Market Size

US$ 1,633.4 Mn

Base year value

2025 Forecast

US$ 7,685.4 Mn

Projected by 2025

CAGR 2018-2025

21.4 %

Growth rate

Addressable Market

US$ 34,450.55 Mn

(2018-2025)

The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

The growth of the market is driven by the factors such as, technological advancements in sequencing and development in genomics. However, the market is likely to get impacted due to nonexistence of skilled professionals and high risks associated with genetic data in next generation sequencing in the region.

Advancement in the field of molecular biology has equally enhanced the sequencing procedures. Many industry players have come up with innovative NGS technology in last few years. The techniques such as cloning, gene sequencing, genome engineering has results into the generation of genetically modified organisms. The technological advancement as headed emergence of the New Bioeconomy, which is the replacement of petrochemical-based manufacturing and fermentation-based manufacturing products. For instance, in October 2018, Roche launched three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits, the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. The kits detect all four mutation classes in solid tumors, complement Roche’s NGS ctDNA kits for oncology research. Additionally, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION. Additionally, three advances NSG systems that dominate the market includes Roche GS FLX, Illumina HiSeq 2000 and AB SOLiD.

NGS makes sequence based gene expression analysis a “digital” alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing have added various solution for most of the industries such as, pharmaceutical and agriculture. These technological advancement are likely to grow the market in near future. Thus, technological advancements are expected to bring about innovative treatments in the market thereby driving the Europe next generation sequencing market growth over the forecast years.


Germany is expected to lead the market in the Europe region owing to increasing funds and growing number of cancer patients in the country. Moreover, increasing focus of on R&D is helps to drive the market growth in the forecast period. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.

Rest of Europe Next Generation Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)

68DnTdg+0IAAQQQQAABBBCoEyBwdYa2gAACCCCAAAIItBIgcK247QwBBBBAAAEEEKgTIHB1hraAAAIIIIAAAgi0EiBwrbjtDAEEEEAAAQQQqBMgcHWGtoAAAggggAACCLQSIHCtuO0MAQQQQAABBBCoEyBwdYa2gAACCCCAAAIItBIgcK247QwBBBBAAAEEEKgTIHB1hraAAAIIIIAAAgi0EiBwrbjtDAEEEEAAAQQQqBMgcHWGtoAAAggggAACCLQSIHCtuO0MAQQQQAABBBCoEyBwdYa2gAACCCCAAAIItBIgcK247QwBBBBAAAEEEKgTIHB1hraAAAIIIIAAAgi0EiBwrbjtDAEEEEAAAQQQqBMgcHWGtoAAAggggAACCLQSIHCtuO0MAQQQQAABBBCoEyBwdYa2gAACCCCAAAIItBIgcK247QwBBBBAAAEEEKgT+D9IxMHj8VgffwAAAABJRU5ErkJggg==
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

EUROPE NEXT GENERATION SEQUENCING - MARKET SEGMENTATION


By Product


• Consumables• Services• Platforms

By Technology


• Genome Sequencing • Exome Sequencing • Resequencing & Targeted Sequencing• Other

By Application


• Diagnostics• Drug Discovery • Precision Medicine • Others

By End User


• Academic & Research Institutes• Pharmaceutical & Biotechnology Companies• Hospitals & Clinics• Others

By Geography


• Europe• UK• Germany• France

Company Profiles


• Illumina, Inc.• Thermo Fisher• Qiagen N.V.,• Beijing Genomics Institute• PerkinElmer, Inc.• F.Hoffman-La Roche Ltd.• Agilent Technologies• Eurofins Scientific• Oxford Nanopore Technologies Ltd.• Macrogen Inc.

Europe Next Generation Sequencing Report Scope

Report Attribute Details
Market size in 2017 US$ 1,633.4 Million
Market Size by 2025 US$ 7,685.4 Million
CAGR (2018 - 2025) 21.4%
Historical Data 2015-2016
Forecast period 2018-2025
Segments Covered By Product
  • Platforms
  • Services
  • Consumables
By Service
  • Genome Sequencing
  • Exome Sequencing
  • Resequencing Targeted Sequencing
  • & Other Sequencing Technologies
By Application
  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • & Other Applications
By End User
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals Clinics
  • Other End Users
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Illumina, Inc.
  • Thermo Fisher
  • Qiagen N.V.,
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA